Inventor

GUZI TIMOTHY J

US58 patents

⚠️ This page may combine multiple inventors who share the name “GUZI TIMOTHY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GUZI TIMOTHY J

SCHERING CORP

Imidazopyrazines as cyclin dependent kinase inhibitors

Farnesyl protein transferase inhibitors

Farnesyl protein transferase inhibitors

Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors

N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors

Imidazopyrazines as cyclin dependent kinase inhibitors

Imidazopyrazines as protein kinase inhibitors

Pyrazolotriazines as kinase inhibitors

Imidazopyridines as cyclin dependent kinase inhibitors

Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors

Imidazopyridines as cyclin dependent kinase inhibitors

Imidazopyrazines as cyclin dependent kinase inhibitors

17-β hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

Imidazopyrazines as protein kinase inhibitors

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

Farnesyl protein transferase inhibitors as antitumor agents

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors

Imidazopyrazines as cyclin dependent kinase inhibitors

Pyrazolotriazines as kinase inhibitors

Pyrazolotriazines as kinase inhibitors

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors

Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

PHARMACOPEIA DRUG DISCOVERY

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

Pyrazolopyrimidines as cyclin dependent kinase inhibitors

GUZI TIMOTHY J

Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors

Methods for inhibiting protein kinases

Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors

Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors

SHIPPS JR GERALD W

2-aminothiazole-4-carboxylic amides as protein kinase inhibitors

Anilinopiperazine derivatives and methods of use thereof

SCHERING CORPOARTION

Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors

REDDY PANDURANGA ADULLA P

Heterocyclic amide compounds as protein kinase inhibitors

BOGEN STEPHANE L

Substituted piperidines that increase p53 activity and the uses thereof